About

Dr. Hathaway’s research focuses on unraveling the mechanisms of epigenetic gene regulation by developing chemical biology-based tools that can control chromatin state and consequently gene expression. Our team is currently working on applying these chemical epigenetic modifying technologies to regulate genetic payloads from gene therapeutic vectors. Our ultimate goal is to develop a versatile solution that can use this dose responsive platform effectively address rare monogenic diseases.